Combined use of a fibrate and orlistat for the treatment of obesity
作者： Alan Edgar
DOI:
关键词: Orlistat 、 Bioinformatics 、 Obesity 、 Medicine 、 Fibrate 、 Combined use
摘要: The present invention relates to the use of a fibrate and orlistat treat patients suffering from obesity.
lens.org 参考文章(4)
A. Brian Jones, Kun Liu, Libo Xu, Aryloxyacetic acids for diabetes and lipid disorders ,(2001)
F.P Mancini, A Lanni, L Sabatino, M Moreno, A Giannino, F Contaldo, V Colantuoni, F Goglia, Fenofibrate prevents and reduces body weight gain and adiposity in diet-induced obese rats FEBS Letters. ,vol. 491, pp. 154- 158 ,(2001) , 10.1016/S0014-5793(01)02146-9
Marsha C. Tolentino, Andrea Ferenczi, Laura Ronen, Leonid Poretsky, Combination of gemfibrozil and orlistat for treatment of combined hyperlipidemia with predominant hypertriglyceridemia. Endocrine Practice. ,vol. 8, pp. 208- 212 ,(2002) , 10.4158/EP.8.3.208
William N. Washburn, Bruce Ellsworth, Philip M. Sher, Wei Meng, Gang Wu, C-aryl glucoside SGLT2 inhibitors ,(2000)